Gainers Valneva (NASDAQ:VALN) shares rose 20.6% to $7.09 during Wednesday's after-market sessio

Peer-Reviewed Paper Introduces QRX003 and Its Mechanism of Action in Netherton SyndromeCase Report D

Peer-Reviewed Paper Introduces QRX003 and Its Mechanism of Action in Netherton Syndrome Case Report

Lake Street analyst Thomas Flaten initiates coverage on Quoin Pharmaceuticals (NASDAQ:QNRX) with

–   First-Ever Fast Track Designation Granted for a Peeling Skin Syndrome Therapy –  Second Fast Tra

Gainers AEON Biopharma (AMEX:AEON) stock moved upwards by 8.9% to $0.32 during Thursday's after

Quoin Pharmaceuticals releases a new NETHERTON NOW video featuring Laura Wright-Sexton, MD, who firs

Second Rare Pediatric Disease (RPD) Designation for QRX003 FDA Previously Granted RPD Designation fo

Second Rare Pediatric Disease (RPD) Designation for QRX003FDA Previously Granted RPD Designation for

Second Rare Pediatric Disease (RPD) Designation for QRX003 FDA Previously Granted RPD Designation fo

Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 24.6% to $6.42 during Friday's regular

US stocks up, Dow gains 100 points, S&P 500 and NASDAQ also rise. Communication services up 1.1%

Shares of Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) are rallying Friday morning following back-to-bac

Shares of Quoin Pharmaceuticals are rallying Friday after pre-market updates on positive trial resul

Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 41.4% to $7.29 during Friday's pre-mark

AFRM: 13% | Affirm Holdings shares are trading higher after the company reported strong Q4 financial

Elastic NV (ESTC) stock rose 21.8% in pre-market trading after reporting strong Q1 results and raisi

ASHBURN, Va., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Comp

Interim Analysis of the First Six Patients to Complete 12 Weeks of Treatment Met Pre-Specified Alpha

Gainers MDxHealth (NASDAQ:MDXH) stock moved upwards by 120.8% to $1.02 during Friday's regular

Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(1.90) per share which missed the

– Receives FDA Conditional Approval of QYLEKI™ as the Proposed Brand Name for QRX003 for Netherton S

ASHBURN, Va., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Comp

Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) shares moved upwards by 41.1% to $0.09 during Frida

Quoin Pharmaceuticals (NASDAQ: QNRX) receives FDA IND clearance for a Phase 2 study of QRX003 in Pee

ASHBURN, Va., June 30, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd.

Gainers Pulsenmore (NASDAQ:PLSM) stock increased by 152.0% to $8.59 during Wednesday's pre-mark

Leifras Co Ltd (NASDAQ: LFS) rose in pre-market trading after acquiring SWIFT JAPAN for JPY454.6 mil

Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 40.3% to $4.56 during Tuesday's after-m

QRX003 Holds Orphan Drug Designation in the United States, the European Union, and Japan, Plus Fast

Supports Quoin's planned direct commercialization of QRX003 in Japan, one of its three core commerci

Four of Six Patients Participating in the Compassionate Use Program Were Classified as ‘Improved' or

-Designation provides regulatory and development incentives in Japan, including up to 10 years of ma

-First ever IND submission for this disease, which has no current treatment or cure- -Quoin plans Ph

- Filed Breakthrough Medicine Designation Application with Saudi FDA for QRX003 in Netherton Syndrom

ASHBURN, Va., April 30, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Com